About Pyramid Bio
Pyramid Bio is a company based in Waltham (United States) founded in 2015. Pyramid Bio has raised $71.19 million across 5 funding rounds from investors including AUM 13F, Adage Capital Management and Prospect Hill Growth Partners. The company has 3 employees as of December 31, 2020. Pyramid Bio operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Waltham, United States
- Employees 3 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pyramid Biosciences, Inc.,
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$71.19 M (USD)
in 5 rounds
-
Latest Funding Round
$33.54 M (USD), Series C
Oct 15, 2021
-
Investors
AUM 13F
& 2 more
-
Employee Count
3
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Pyramid Bio
Unlock access to complete
Funding Insights of Pyramid Bio
Pyramid Bio has successfully raised a total of $71.19M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $33.54 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pyramid Bio
Pyramid Bio has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include AUM 13F, Adage Capital Management and Prospect Hill Growth Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about the company's activities.
|
Locked | Locked | Locked | |
|
Offers investment management and secure information access to clients and partners.
|
Locked | Locked | Locked | |
|
Due diligence tools for asset managers
|
Locked | Locked | Locked |
Investor details for Pyramid Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pyramid Bio
Investment portfolio details for Pyramid Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pyramid Bio
Detailed financials for Pyramid Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pyramid Bio Comparisons
Peer comparison for Pyramid Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pyramid Bio
Pyramid Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Pyramid Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pyramid Bio
Complete news archive for Pyramid Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pyramid Bio
Pyramid Bio was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Pyramid Bio is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Pyramid Bio is a funded company, having raised a total of $71.19M across 5 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Pyramid Bio is 3.
Pyramid Bio was founded in 2015 and is based in Waltham, United States. Small molecules are developed by the company for dermatology and oncology disorders. The lead candidate, PBI-100, functions as a selective TRK modulator with anti-inflammatory and antiproliferative effects and is advanced for psoriasis and atopic dermatitis in phase 1 trials. Another candidate, PBI-200, serves as a TRK inhibitor for solid and liquid tumors.
Pyramid Bio's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Pyramid Bio has 3 investors. Key investors include AUM 13F, Adage Capital Management, and Prospect Hill Growth Partners.